noncompetitive antagonist

noncompetitive antagonist

see noncompetitive antagonism.
References in periodicals archive ?
The "glutamatergic hypothesis" of schizophrenia originated from observations that administration of NMDAR noncompetitive antagonists exacerbates psychotic symptoms in schizophrenics and mimics schizophrenia in nonpsychotic subjects (Coyle et al.